1 - 10 out of 17Page size: 10
  1. 2022

  2. Can serum biomarkers predict the outcome of systemic immunosuppressive therapy in adult atopic dermatitis patients?

    Hurault, G., Roekevisch, E., Schram, M. E., Szegedi, K., Kezic, S., Middelkamp-Hup, M. A., Spuls, P. I. & Tanaka, R. J., Mar 2022, In: Skin health and disease. 2, 1, e77.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. 2020

  4. Effect of immunosuppressive treatment on biomarkers in adult atopic dermatitis patients

    Roekevisch, E., Szegedi, K., Hack, D. P., Schram, M. E., Res, P. C. J. M., Bos, J. D., Leeflang, M. M. G., Luiten, R. M., Kezic, S., Spuls, P. I. & Middelkamp-Hup, M. A., 1 Jul 2020, In: Journal of the European Academy of Dermatology and Venereology. 34, 7, p. 1545-1554 10 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. 2018

  6. Effects of systemic immunosuppressive therapies for moderate-to-severe eczema in children and adults

    Küster, D., Spuls, P. I., Flohr, C., Smith, C., Hooft, L., Deckert, S., Schwennesen, T., Roekevisch, E. & Schmitt, J., 2018, In: Cochrane database of systematic reviews (Online). 2018, 8, CD011939.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. Methotrexaat versus azathioprine Bij patiënten met atopische dermatitis

    Roekevisch, E., 2018, In: Nederlands tijdschrift voor dermatologie en venereologie. 28, 3, p. 63-64

    Research output: Contribution to journal › Article › Professional

  8. Methotrexate and azathioprine in severe atopic dermatitis: a 5-year follow up study of a randomised controlled trial

    Gerbens, L. A. A., Hamann, S. A. S., Brouwer, M. W. D., Roekevisch, E., Leeflang, M. M. G. & Spuls, P. I., 2018, In: British journal of dermatology. 178, 6, p. 1288-1296

    Research output: Contribution to journal › Article › Academic › peer-review

  9. Methotrexate versus azathioprine in patients with atopic dermatitis: 2-year follow-up data

    Roekevisch, E., Schram, M. E., Leeflang, M. M. G., Brouwer, M. W. D., Gerbens, L. A. A., Bos, J. D. & Spuls, P. I., 2018, In: Journal of allergy and clinical immunology. 141, 2, p. 825-+

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  10. Relationship and probabilistic stratification of Eczema Area and Severity Index and objective Scoring Atopic Dermatitis severity scores for atopic dermatitis

    Hurault, G., Schram, M. E., Roekevisch, E., Spuls, P. I. & Tanaka, R. J., 2018, In: British journal of dermatology. 179, 4, p. 1003-1005

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  11. Systemic Treatment in Atopic Dermatitis

    Roekevisch, E., 2018, 209 p.

    Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

  12. 2017

  13. Patients with atopic dermatitis with filaggrin loss-of-function mutations show good but lower responses to immunosuppressive treatment

    Roekevisch, E., Leeflang, M. M. G., Schram, M. E., Campbell, L. E., Irwin McLean, W. H., Kezic, S., Bos, J. D., Spuls, P. I. & Middelkamp-Hup, M. A., 2017, In: British journal of dermatology. 177, 6, p. 1745-1746

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  14. 2015

  15. Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres

    Garritsen, F. M., Roekevisch, E., van der Schaft, J., Deinum, J., Spuls, P. I. & de Bruin-Weller, M. S., 2015, In: Journal of the European Academy of Dermatology and Venereology. 29, 10, p. 1905-1912

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1 2 Next

ID: 81134